argenx SE (EBR:ARGX)
556.60
+5.80 (1.05%)
Aug 14, 2025, 5:35 PM CET
argenx SE Revenue
argenx SE had revenue of $967.19M USD in the quarter ending June 30, 2025, with 97.62% growth. This brings the company's revenue in the last twelve months to $3.12B, up 88.04% year-over-year. In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth.
Revenue (ttm)
$3.12B
Revenue Growth
+88.04%
P/S Ratio
12.69
Revenue / Employee
$1.95M
Employees
1,599
Market Cap
33.71B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.25B | 979.61M | 77.22% |
Dec 31, 2023 | 1.27B | 827.58M | 187.66% |
Dec 31, 2022 | 441.01M | -87.25M | -16.52% |
Dec 31, 2021 | 528.27M | 466.31M | 752.59% |
Dec 31, 2020 | 61.96M | -30.85M | -33.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 6.85B |
Financière de Tubize | 13.26K |
Fagron NV | 918.75M |
Ion Beam Applications | 498.16M |
Nyxoah | 4.36M |
Onward Medical | 1.74M |
Hyloris Pharmaceuticals | 9.76M |
Sequana Medical NV | 105.50K |
argenx SE News
- 1 day ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - GlobeNewsWire
- 1 day ago - Monica Seles: Reveals Myasthenia Gravis Diagnosis; champion's battle against Autoimmune Disease - The Times of India
- 2 days ago - argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis - GlobeNewsWire
- 3 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - PRNewsWire
- 5 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - GlobeNewsWire
- 6 days ago - Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Benzinga
- 6 days ago - Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts - Seeking Alpha
- 8 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - PRNewsWire